SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001654954-21-003529
Filing Date
2021-03-30
Accepted
2021-03-30 16:53:24
Documents
7
Period of Report
2021-01-15
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDED CURRENT REPORT tenx_8ka.htm 8-K/A 36516
2 CONSENTS OF EXPERTS AND COUNSEL tenx_ex23-1.htm EX-23.1 4257
3 AUDITED FINANCIAL STATEMENTS OF PHPRECISIONMED INC. AS OF AND FOR THE YEAR ENDED tenx_ex992.htm EX-99.2 115013
4 UNAUDITED FINANCIAL STATEMENTS OF PHPRECISIONMED INC. AS OF AND FOR THE NINE MON tenx_ex993.htm EX-99.3 152604
5 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF THE COMPANY AS O tenx_ex994.htm EX-99.4 301481
6 IMAGE cherry.jpg GRAPHIC 2929
7 IMAGE footer.jpg GRAPHIC 1356
  Complete submission text file 0001654954-21-003529.txt   617412
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-34600 | Film No.: 21787021
SIC: 2834 Pharmaceutical Preparations